Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA

OBJECTIVE: To examine the effects of belimumab initiation on healthcare resource utilisation (HCRU) and costs in SLE. METHODS: This retrospective observational cohort study used healthcare administrative claims data from the IBM MarketScan Commercial Claims and Encounters Database to identify patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Christopher F, Priest, Julie, Stott-Miller, Marni, Kan, Hong, Amelio, Justyna, Song, Xue, Limone, Brendan, Noxon, Virginia, Costenbader, Karen H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Epidemiology and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174061/
https://www.ncbi.nlm.nih.gov/pubmed/32341790
http://dx.doi.org/10.1136/lupus-2019-000357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174061/
https://www.ncbi.nlm.nih.gov/pubmed/32341790
http://dx.doi.org/10.1136/lupus-2019-000357

Ejemplares similares